IP Library Granted Patent US 8,753,316
Granted Patent B2
US 8,753,316 · App. 13/477,679 · Granted Jun 17, 2014

Insulin pump for determining carbohydrate consumption

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,753,316
App. No.
13/477,679
Granted
Jun 17, 2014
Kind
B2
Abstract

Methods of regulating blood glucose using an insulin pump are disclosed. A method includes storing a target blood glucose level in the pump. The method also includes receiving a current blood glucose level, and comparing the current blood glucose level to the target blood glucose level. The method further includes, upon detection of a current blood glucose level lower than the target blood glucose level, calculating a carbohydrate value required to change the current blood glucose level to the target blood glucose level.

Claims (17)

1. An insulin pump comprising:

a pump mechanism;

a memory configured to store a target blood glucose level;

a programmable circuit arranged to control the pump mechanism and operatively connected to the memory, the programmable circuit programmed to:

receive a current blood glucose level;

compare the current blood glucose level to the target blood glucose level; and

upon detection of a current blood glucose level lower than the target blood glucose level, calculate, based on a difference between the current blood glucose level and the target blood glucose level, a carbohydrate value required to raise the current blood glucose level to the target blood glucose level.

2. The insulin pump of claim 1 , wherein, upon detection of a current blood glucose level lower than the target blood glucose level, issuing an alert.

3. The insulin pump of claim 2 , wherein the alert is a message notifying the user that the user's blood glucose level is below the target blood glucose level.

4. The insulin pump of claim 1 , wherein the programmable circuit is further programmed to display the carbohydrate value as a suggestion to the user to consume the carbohydrate value.

5. The insulin pump of claim 4 , wherein the programmable circuit is further programmed to allow editing of the displayed carbohydrate value.

6. The insulin pump of claim 5 , wherein the programmable circuit is further programmed to, upon determining that the displayed carbohydrate value is greater than the carbohydrate value required to change the current blood glucose level to the target blood glucose level, calculate an insulin meal bolus.

7. The insulin pump of claim 6 , wherein the programmable circuit is further programmed to deliver the insulin meal bolus.

8. The insulin pump of claim 1 , wherein the programmable circuit uses one or more correction factors to calculate the carbohydrate value.

9. The insulin pump of claim 1 , wherein the programmable circuit is further programmed to calculate a future blood glucose level based on the current blood glucose level and an insulin on board amount.

10. The insulin pump of claim 9 , wherein the programmable circuit is further programmed to, upon detection of the future blood glucose level lower than the target blood glucose level, calculate a carbohydrate value required to change the future blood glucose level to the target blood glucose level.

11. The insulin pump of claim 1 , wherein the programmable circuit is further programmed to display the current blood glucose level.

Assignments (9)
RELEASE OF SECURITY INTEREST Recorded Mar 24, 2024
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: TANDEM DIABETES CARE, INC.
Reel/Frame 066880/0918 →
SECURITY INTEREST Recorded May 25, 2022
From: TANDEM DIABETES CARE, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 060179/0100 →
RELEASE OF SECURITY INTEREST Recorded Aug 10, 2018
From: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II L.P. - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II (CAYMAN) L.P.
To: TANDEM DIABETES CARE, INC.
Reel/Frame 046761/0843 →
RELEASE OF SECURITY INTEREST Recorded Aug 10, 2018
From: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II L.P. - PARALLEL FUND "A" L.P.
To: TANDEM DIABETES CARE, INC.
Reel/Frame 046763/0268 →
SHORT-FORM PATENT SECURITY AGREEMENT Recorded Apr 4, 2014
From: TANDEM DIABETES CARE, INC.
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II (CAYMAN) L.P.
Reel/Frame 032608/0780 →
SHORT-FORM PATENT SECURITY AGREEMENT Recorded Dec 26, 2012
From: TANDEM DIABETES CARE, INC.
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.
Reel/Frame 029529/0886 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 12, 2012
From: SMITHS MEDICAL ASD, INC.
To: TANDEM DIABETES CARE, INC.
Reel/Frame 029121/0430 →
MERGER Recorded Jul 31, 2012
From: SMITHS MEDICAL MD, INC.
To: SMITHS MEDICAL ASD, INC.
Reel/Frame 028689/0474 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 31, 2012
From: BLOMQUIST, MICHAEL L.
To: SMITHS MEDICAL MD, INC.
Reel/Frame 028686/0904 →